United Gene High-Tech Group Limited provided consolidated earnings guidance for the year ended June 30, 2013. The company announced based on a preliminary review by the board of directors of the company of the unaudited consolidated management accounts of the group for the year ended 30 June 2013, the board informed the shareholders of the company and potential investors that the group is expected to record a substantial decrease in turnover and continue to record a loss for the year ended 30 June 2013 as compared to that for the year ended 30 June 2012. Based on the preliminary review of the relevant information currently available to the company, such decrease in turnover was mainly attributable to a significant reduction in turnover in distribution of gene testing services and such loss was mainly attributable to impairment losses attributable to the tangible and intangible assets and continuing loss in business segments.